Purchase Order SPE2DP25V3426
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded SZY Holdings, LLC a $1,879.06 firm fixed-price purchase order for Ciprofloxacin tablets on July 29, 2025. This contract contains no set-aside designation and is scheduled for ultimate completion by October 6, 2025. SZY Holdings, a Brooklyn, New York-based manufacturer of medical equipment and supplies registered in the System for Award Management since 2006, will perform the work at its facility in Brooklyn. The company...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,194 firm fixed-price purchase order to SZY Holdings, LLC for intravenous injection supplies. The contract, awarded on July 24, 2025, with an ultimate completion date of September 25, 2025, represents a standard procurement with no set-aside designation. Performance will take place in Brooklyn, New York, where SZY Holdings maintains its headquarters and primary operations. SZY Holdings is an established medical...
- This purchase order contract, valued at approximately $199, was awarded by the Defense Logistics Agency Troop Support Medical to SZY Holdings LLC for the delivery of cephalothin disks. The contract has a period of performance from September 1-21, 2023. SZY Holdings will provide the requested pharmaceutical products to the agency from its place of performance in Brooklyn, New York. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense...
- This is a firm-fixed-price purchase order awarded by the Defense Logistics Agency's Medical Supply Chain division to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract, valued at $2,902.62, is for the delivery of MOXIFLOXACIN HYDROC (8510390403), a pharmaceutical product, with a completion date of February 20, 2024. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. The...
- This federal contract award, SPE2DP24P0065, was issued by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The $2,117.75 firm-fixed-price purchase order is for the delivery of moxifloxacin hydrochloride, a pharmaceutical product, with a completion date of November 13, 2023. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. This award is not...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract, valued at $1,310.64, is for the delivery of MOXIFLOXACIN HYDROC, a pharmaceutical product, with a completion date of May 19, 2023. SZY Holdings, a manufacturer of medical equipment, supplies, and consumables, has a strong track record of securing federal contracts with the DLA, including an Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,147 firm fixed-price purchase order to SZY Holdings, LLC on August 18, 2025, for an administration set. The contract, which carries no set-aside designation, is scheduled for completion by November 3, 2025, with performance taking place in Brooklyn, New York. SZY Holdings is a medical equipment and supplies manufacturer based in Brooklyn that has maintained an active System for Award Management registration since...
- This is a firm-fixed-price purchase order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract has a ceiling value of $2,122.40 and an ultimate completion date of July 10, 2025. The contract is not set aside for any specific business type. SZY Holdings, LLC is a manufacturer of medical equipment, supplies, and consumables that has been awarded numerous...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price purchase order to SZY Holdings, LLC for azithromycin on August 19, 2025, with a ceiling value of $2,221.76 and ultimate completion date of October 27, 2025. This contract represents a standard procurement with no set-aside designation. The work will be performed in Brooklyn, New York, where SZY Holdings maintains its primary operations. As a registered manufacturer and supplier of medical equipment,...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $8,590.08 firm fixed-price purchase order to SZY Holdings, LLC on May 9, 2025, for the procurement of Moxifloxacin Hydrochloride, an antibiotic pharmaceutical used in military and federal healthcare programs. This standard purchase order, which carries no set-aside designation, is scheduled for completion by July 14, 2025, with performance taking place at the contractor's facility in Brooklyn, New York. The award supports the...
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,956 firm fixed-price purchase order to SZY Holdings, LLC for the supply of Cefoxitin for injection. This contract, awarded on August 20, 2025, represents a standard procurement with no set-aside designation and an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Brooklyn, New York, where SZY Holdings maintains its primary operations. As a manufacturer of medical equipment, supplies, and consumables, SZY Holdings has established itself as a reliable federal contractor since its registration with the System for Award Management in 2006. SZY Holdings' selection for this medical supply contract aligns with the company's demonstrated experience serving the Defense Logistics Agency across multiple divisions, including the Medical Supply Chain, Aviation, Land and Maritime, Subsistence, and Construction and Equipment programs. The contractor maintains a robust portfolio of federal contracts ranging from small purchases to larger orders, with previous contract values exceeding $8,000 and a notable indefinite delivery contract valued at $250,000 with the DLA Aviation division. This purchase order for Cefoxitin contributes to the Defense Logistics Agency's mission of procuring essential medical supplies for U.S. military health programs and demonstrates SZY Holdings' capability to fulfill pharmaceutical procurement requirements for federal government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/20/25 |